CiToxLAB Revenue and Competitors

The Citoxlab Group offers a comprehensive range of preclinical services and specialty safety evaluation services to meet the needs of pharmaceutical, biotechnology and chemical companies worldwide.\n\nOur nine Citoxlab international facilities in France, Canada, USA, Denmark and Hungary carry out studies in general and reproductive toxicology, carcinogenicity, bioanalysis, DMPK, Pharmacokinetics, Toxicokinetics, ADME, immunology and safety pharmacology. The group has special expertise in areas such as inhalation or intra-nasal toxicology, radiation safety (ARS), NHPs and minipigs. Environmental studies are a further specialty including ecotoxicology and those related to REACH regulations.\nTogether with partners such as Atlanbio (St Nazaire, France) Stemina (Madison, USA), Citoxlab also provides services such as clinical bioanalysis and embryonic stem cell biomarker discovery.\n\nCitoxlab now offers flexibility, direct contact to scientists, easy access to management and local, smart-sized facilities. Aggressive scheduling, increased size and capacity, turnkey solutions of global packages supported by project managers and broader geographic proximity are core values of Citoxlab. \n\nContact our team of experts: www.citoxlab.com